Our study also demonstrated that patients with high SFXN1 expression had a significantly higher TMB, which is consistent with previous findings linking high TMB to a poor prognosis for non-small cell lung cancer [32]. This evidence concerns the gene SFXN1 and non-small cell lung carcinoma.